Advanced Urothelial Carcinoma VL

Updates on Health-Related Quality-of-Life (HRQoL) analyses in GU Oncology - Cora Sternberg

Cora Sternberg highlights from a number of key treatments in GU Oncology in a discussion with Alicia Morgans. Results from the only Phase 3 health-related quality-of-life (HRQoL) analyses in urothelial carcinoma from the KEYNOTE-045 study delivers results for patients who received 2 nd line therapy. A relevant discussion follows on a Phase 2 trial investigating 3 different dosing regimens of radiu...

Immune Checkpoint Inhibitors and the Effects on Anti-Tumor Response - Daniel Petrylak

Dr. Daniel Petrylak describes what an immune checkpoint inhibitor is and how this may effect an anti-tumor response. The immune system has several key attributes- it is specific, it has a memory and it can adapt to changes that are going on with tumor cells. He goes on to describe the mechanisms involved in the cancer cells response. (presentation in 2:40). BIOGRAPHY As Professor of Medicine and U...